CSL Aktie

 

These ASX healthcare shares may not regain investor confidence overnight, but I think they are worth studying while sentiment is weak. The post Are CSL and ResMed shares buys at 52-week lows? appeared first on The Motley Fool Australia....

It looks like brokers have lost confidence in one of these shares. The post WiseTech, Cochlear, CSL shares: Can these beaten down stocks rebound in 2026? appeared first on The Motley Fool Australia....

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

CSL's yield now rivals a big four bank... The post Historic: Here's why CSL shares are looking very interesting right now appeared first on The Motley Fool Australia....

CSL is at a 10-year low. Cochlear has fallen 62%. ResMed is down on fears that proved wrong. Are any of the three worth buying now? The post These 3 ASX healthcare stocks have been crushed in 2026. They could be set for a comeback appeared first on The Motley Fool Australia....

Here's what I expect from the beaten-down biotech stock next month. The post Should I buy CSL shares in June? appeared first on The Motley Fool Australia....

Insiders are buying after a brutal CSL share price fall. The post After CSL's 60% share price crash, insiders are starting to buy appeared first on The Motley Fool Australia....

Market caution can be frustrating, but it can also create opportunities for investors willing to look beyond the next result. The post Down 40%+! I'd buy CSL and these ASX shares while investors are still cautious appeared first on The Motley Fool Australia....

These beaten-down ASX shares still have risks, but I think their long-term growth stories remain compelling. The post Why I'd buy DroneShield, CSL, and WiseTech shares right now appeared first on The Motley Fool Australia....

CSL shares are back below $100 after a brutal sell-off. The post Under $100, are CSL shares finally too cheap to ignore? appeared first on The Motley Fool Australia....

Can this giant produce healthy returns or is there more downside to come? The post Here are the latest growth forecasts for the CSL share price appeared first on The Motley Fool Australia....

This ASX healthcare giant has fallen hard, but the lower price and improving dividend appeal make it worth another look. The post Should I invest $10,000 in CSL shares before the end of May? appeared first on The Motley Fool Australia....

Has the market become too pessimistic about Australia's biotech giant? The post CSL shares crash, but is a comeback looming? appeared first on The Motley Fool Australia....

Do analysts rate these popular shares as buys? Let's find out. The post Buy, hold, sell: CBA, CSL, and Life360 shares appeared first on The Motley Fool Australia....

There is no hiding from the bloody mess at CSL, one of Australia's global success stories. Can it recover?...

Is there more pain in store for CSL shareholders? The post Where to from here for CSL shares according to Macquarie appeared first on The Motley Fool Australia....

Japan-Takeda radiert 280 Jobs in Zürich-Opfikon aus, australische CSL Behring vernichtet 200 Stellen in Bern, Novartis 500. Black Hour. Die Schweiz, das Pharma-Paradies. Und jetzt das. 280 Jobs gehen im Norden des Wirtschaftsmotors Zürich verloren. Das Streichkonzert von Takeda aus Japan, einem globalen Pharma-Riesen, trifft die Schweiz mit Wucht. Das berichtete die NZZ. Gleiches im Berner Vorort Wankdorf, wo […]...

Brokers reduced their ratings on CSL, Graincorp, and other stocks this week. The post 5 ASX shares downgraded by brokers this week appeared first on The Motley Fool Australia....

Investors sent Paladin Energy, CSL, and CBA shares tumbling this week. But why? The post Why CBA, Paladin Energy and CSL shares crashed  9% to 17% this week appeared first on The Motley Fool Australia....